Atacand
Payments companies reported to CMS as associated with Atacand. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Atacand, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Atacand
These are the largest totals companies reported as associated with Atacand. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ara Klijian | Murrieta, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $195.17 |
| Nassir Azimi | La Mesa, CA | Cardiovascular Disease | $195.17 |
| James Elia | Colton, CA | Emergency Medical Services | $195.17 |
| Thomas Lenoir | Ocean Springs, MS | Emergency Medicine | $143.19 |
| Benjamin Holland | Springfield, MO | Emergency Medicine | $143.19 |
| Debra Richardson | Oklahoma City, OK | Gynecologic Oncology | $140.39 |
| Naoko Takebe | Rockville, MD | Hematology & Oncology | $140.39 |
| Hassan Hatoum | Oklahoma City, OK | Hematology & Oncology | $140.39 |
| James Battiste | Oklahoma City, OK | Neurology (Psychiatry & Neurology) | $140.39 |
| Susanna Ulahannan | Ponca City, OK | Hematology & Oncology | $140.39 |
Prescribed Atacand?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.